Arrowhead Pharmaceuticals

ARWR | NASDAQ | 0 Sledující

$16.07

-4.46%

-$0.75

Sledovat

Overview Metrics Financials

Breakdown	9/30/2024 USD	9/30/2023 USD	9/30/2022 USD	9/30/2021 USD
Total revenue	3,551 -98.52%	240,735 -1.03%	243,231 +75.89%	138,287 -
Cost of revenue	0 -	0 -100.00%	10,421 -	0 -
Gross profit	3,551 -98.52%	240,735 +3.40%	232,810 +68.35%	138,287 -
Operating expense	604,631 +35.65%	445,737 +5.69%	421,738 +46.78%	287,323 -
Operating income	-601,080 -193.21%	-205,002 -14.84%	-178,507 -19.77%	-149,036 -
Pretax Income	-612,460 -196.60%	-206,491 -19.56%	-172,709 -22.62%	-140,846 -
Tax Provision	-2,767 -199.39%	2,784 -26.45%	3,785 +189,150.00%	2 -
Net income	-599,493 -192.04%	-205,275 -16.31%	-176,494 -25.31%	-140,848 -
EPS	-5 -161.78%	-1.91 -14.37%	-1.67 -22.79%	-1.36 -
Diluted EPS	-5 -160.42%	-1.92 -14.97%	-1.67 -22.79%	-1.36 -
Average Shares	119,784 +11.62%	107,312 +1.79%	105,426 +1.62%	103,745 -
Diluted Average Shares	119,784 +12.21%	106,750 +1.26%	105,426 +1.62%	103,745 -
EBIT	-580,108 -208.30%	-188,165 -8.95%	-172,709 -22.62%	-140,846 -
EBITDA	-561,513 -219.64%	-175,672 -8.25%	-162,288 -22.41%	-132,580 -

Soubory cookie používáme ke zlepšení prohlížení na webu.